| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Valantine Hannah is a Director at CDNA with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 2,915 | $30.00 | $87,450.00 | -62.3% | +13.7% | -18.3% | |
| Dec 29, 2021 | BBIO Bridgebio Pharma, Inc. | Director | Buy | 1,764 | $14.23 | $25,101.72 | New | -23.5% | -46.7% | |
| Dec 28, 2021 | BBIO Bridgebio Pharma, Inc. | Director | Buy | 3,433 | $12.96 | $44,475.94 | +181.5% | -22.3% | -49.8% |